Firms
Theme

CSTM

Constellium SE Class A · NYSE

News

9 latest

Zacks Investment Research

4 Industrial Stocks Set to Outshine Q3 Earnings Estimates

The Industrial Products sector is projected to see Q3 2026 earnings growth of 14.2% and revenue growth of 8.6%, driven by strong manufacturing demand, aerospace activity, and new orders. However, inflation, supply-chain disruptions, and tariffs pose risks. Four stocks with positive Earnings ESP—CAT, CR, FLS, and CSTM—show potential to beat earnings estimates.

Zacks Investment Research

Constellium (CSTM) Reports Next Week: Wall Street Expects Earnings Growth

Constellium is expected to report Q3 2026 earnings on October 28 with consensus estimates of $0.74 EPS (up 19.4% YoY) and $2.53B in revenues (up 16.9% YoY). The company has a positive Earnings ESP of +14.50% combined with a Zacks Rank #2 (Buy), suggesting a likely earnings beat. Constellium has beaten consensus EPS estimates in all four of the last quarters.

Zacks Investment Research

Why Constellium (CSTM) is Poised to Beat Earnings Estimates Again

Constellium (CSTM), an aluminum company in the Metal Products - Distribution industry, is expected to beat earnings estimates in its next quarterly report on October 28, 2026. The company has a strong track record of beating estimates with an average surprise of 71.66% over the past two quarters, and currently has a positive Earnings ESP of +14.50% combined with a Zacks Rank #2 (Buy) rating, suggesting another earnings beat is likely.

Zacks Investment Research

Wall Street Analysts Believe Constellium (CSTM) Could Rally 35.29%: Here's is How to Trade

Constellium (CSTM) has a mean analyst price target of $34.50, suggesting 35.3% upside potential from its current $25.50 price. The stock holds a Zacks Rank #2 (Buy) rating, supported by positive earnings estimate revisions over the past 30 days. However, the article cautions that price targets alone should not be the sole basis for investment decisions, as analysts often set overly optimistic targets due to business incentives.

Zacks Investment Research

Here's Why Constellium (CSTM) is a Strong Momentum Stock

Zacks Premium offers investment research tools including daily Zacks Rank updates, Style Scores (Value, Growth, Momentum, and VGM), and equity research reports to help investors identify high-performing stocks. The article highlights Constellium (CSTM) as a #2 Buy with strong momentum characteristics and positive earnings revisions.

Zacks Investment Research

Constellium Shares Up 36% YTD: Is It the Right Time to Buy the Stock?

Constellium SE (CSTM) has gained 35.8% year-to-date, outperforming its industry despite recent technical weakness. The company benefits from strong aerospace, packaging, and defense demand, delivering record segment EBITDA in key divisions. With expected 2026 free cash flow exceeding $300 million and a reasonable valuation, analysts maintain a Buy rating despite bearish technical indicators showing a death crossover.

Zacks Investment Research

Constellium (CSTM) is a Top-Ranked Growth Stock: Should You Buy?

Zacks Premium offers investment research tools including the Zacks Rank and Style Scores to help investors identify stocks with strong performance potential. The system rates stocks on value, growth, and momentum metrics, with #1 (Strong Buy) stocks historically averaging +23.86% annual returns since 1988. Constellium (CSTM) is highlighted as a #2 Buy with strong growth prospects.

Mentions CSTM

Zacks Investment Research

Here's Why It is Appropriate to Invest in Emerson Right Now

Emerson Electric (EMR) demonstrates strong growth momentum with 6% underlying sales increase and 7% order growth in Q3 fiscal 2026. The company's strategic acquisitions of Glue Inc. and full ownership of AspenTech expand its software and automation capabilities. Strong free cash flow of $2.62 billion supports shareholder returns through dividends and share buybacks, with a recent 5% dividend increase.

Headlines link to the publisher. Not investment advice.

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Community

7 days

No sentiment yet

Posts 24h
0
Replies 24h
0
Watchers
0

Board · $CSTM · 0 threads

Sign in to post on $CSTM

Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.

Cylvex is a financial simulation and community platform designed for educational and informational purposes only. Market data may be delayed. Nothing on this platform constitutes investment advice, financial advice, trading advice, or any other sort of advice. You should not treat any of the platform's content as such. Cylvex does not recommend that any financial instrument should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions. By using Cylvex, you acknowledge that you are using the platform at your own risk.

Terms · Privacy · Disclaimer · Methodology · Logos provided by Logo.dev